Innovation Pharmaceuticals Inc (IPIX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Innovation Pharmaceuticals Inc (IPIX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010912
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp is a biopharmaceutical company that discovers and advances medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company pipeline products include kevetrin for the treatment of advanced solid tumors and acute myelogenous leukemia; Brilacidin for the treatment of oral mucositis and skin infections; and Prurisol for the treatment of psoriasis.The company works in collaboration with various research institutions across the US and other European countries. Innovation Pharmaceuticals is headquartered in Beverly, Massachusetts, the US.

Innovation Pharmaceuticals Inc (IPIX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Innovation Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Innovation Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Innovation Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Innovation Pharma to Raise USD30 Million in Private Placement of Shares 10
Cellceutix Raises USD16 Million in Private Placement of Common Stock 11
Acquisition 12
Cellceutix Completes Acquisition Of PolyMedix 12
Innovation Pharmaceuticals Inc – Key Competitors 13
Innovation Pharmaceuticals Inc – Key Employees 14
Innovation Pharmaceuticals Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Financial Announcements 16
Feb 16, 2017: Cellceutix Reports on Q2 Fiscal 2017, Prepares for Important Clinical Milestones 16
Nov 14, 2016: Cellceutix Provides Corporate Update and Reports Q1 Fiscal 2017 Financial Results 18
Corporate Communications 22
Sep 16, 2016: Cellceutix Announces Appointment of Vice President for Regulatory Affairs 22
Aug 30, 2016: Cellceutix Further Expands Its Senior Management Team With the Addition of an Industry Veteran 23
Aug 30, 2016: Cellceutix Further Expands Its Senior Managment Team With the Addition of an Industry Veteran 24
Jun 30, 2016: Cellceutix Announces Industry Veteran Arthur P. Bertolino, MD, PhD, MBA Joins Company as President and Chief Medical Officer 25
Mar 08, 2016: Cellceutix Welcomes Dr. Stephen T. Sonis to Its Scientific Advisory Board 26
Legal and Regulatory 27
Jun 07, 2017: Cellceutix Announces Company Name Change to Innovation Pharmaceuticals 27
Other Significant Developments 28
Sep 13, 2016: Cellceutix Provides Business Update and Timeline of Upcoming Milestones 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Innovation Pharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2
Innovation Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Innovation Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Innovation Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8
Innovation Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Innovation Pharma to Raise USD30 Million in Private Placement of Shares 10
Cellceutix Raises USD16 Million in Private Placement of Common Stock 11
Cellceutix Completes Acquisition Of PolyMedix 12
Innovation Pharmaceuticals Inc, Key Competitors 13
Innovation Pharmaceuticals Inc, Key Employees 14

★海外企業調査レポート[Innovation Pharmaceuticals Inc (IPIX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sociedad General de Aguas de Barcelona SA:企業の戦略的SWOT分析
    Sociedad General de Aguas de Barcelona SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • UniCredit S.p.A:戦略・SWOT・企業財務分析
    UniCredit S.p.A - Strategy, SWOT and Corporate Finance Report Summary UniCredit S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PsiOxus Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary PsiOxus Therapeutics Ltd (PsiOxus), formerly known as Myotec Therapeutics Ltd, is a drug company that develops novel therapeutics for cancer and other clinically unmet diseases. The company's pipeline product portfolio includes an oncolytic vaccine and a dual action anabolic catabolic transf …
  • Caladrius Biosciences Inc (CLBS):企業の財務・戦略的SWOT分析
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a clinical-stage biopharmaceutical company. The company develops cellular therapies for the treatment cardiovascular indications and autoimmune diseases. The company's products pipeline includes CLBS03 is an autologous ex vivo p …
  • Shop Direct Holdings Limited:企業の戦略・SWOT・財務情報
    Shop Direct Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Shop Direct Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Esprit Holdings Limited:戦略・SWOT・企業財務分析
    Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Dangote Cement Plc:企業の戦略・SWOT・財務情報
    Dangote Cement Plc - Strategy, SWOT and Corporate Finance Report Summary Dangote Cement Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Secom Co., Ltd.:企業の戦略・SWOT・財務情報
    Secom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Secom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Metabolomic Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Metabolomic Diagnostics Ltd (Metabolomic Diagnostics) is an early stage medical diagnostic company that develops technology to provide predictive diagnosis of pre-eclampsia in early pregnancy. The company uses metabolic profiling for investigating the low molecular weight biochemicals existi …
  • Peter MacCallum Cancer Centre:製薬・医療:M&Aディール及び事業提携情報
    Summary Peter MacCallum Cancer Centre (Peter Mac) is a provider of public health services. It serves as a cancer research, treatment and education centre. The centre provides wide range of services including diagnostic, radiation therapy, treatment, cancer information and support services. It works …
  • Hansteen Holdings PLC:企業のM&A・事業提携・投資動向
    Hansteen Holdings PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hansteen Holdings PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Cereno Scientific AB (CRNO TO):製薬・医療:M&Aディール及び事業提携情報
    Summary Cereno Scientific AB (Cereno Scientific) is a developer of preventive drugs that normalize the body's own defense system against blood clots. The company develops drugs in the therapeutic area of thrombosis-related cardiovascular diseases. Its lead product candidate CS1 is being developed fo …
  • Ilyushin Aviation Complex OJSC:企業の戦略・SWOT・財務情報
    Ilyushin Aviation Complex OJSC - Strategy, SWOT and Corporate Finance Report Summary Ilyushin Aviation Complex OJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • LifeLabs Inc-医療機器分野:企業M&A・提携分析
    Summary LifeLabs Inc (LifeLabs) is a laboratory testing service provider that monitors heart disease and identifies neurological disorders and pinpoint allergies. The laboratory's services include clinical studies and services, drug and alcohol screening, employee wellness, hospital lab services, me …
  • CJ ENM Co Ltd (035760):企業の財務・戦略的SWOT分析
    CJ ENM Co Ltd (035760) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Tibet Rhodiola Pharmaceutical Holding Co Ltd (600211):企業の財務・戦略的SWOT分析
    Summary Tibet Rhodiola Pharmaceutical Holding Co Ltd (TRPHC) is a pharmaceutical company that manufactures and markets Chinese medicine. The company’s products include children shuangqing particles, little dragon capsule, nuodikang capsule, shuxioang capsules, snowy jin luohan analgesic balm, pu yu …
  • Concord New Energy Group Ltd (182):電力:M&Aディール及び事業提携情報
    Summary Concord New Energy Group Limited (Concord), formerly China WindPower Group Limited, is a clean and renewable energy company that carries out the construction, operation and maintenance of, and investment in, wind and solar power electricity generating facilities in China. Concord’s core busi …
  • PsiOxus Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary PsiOxus Therapeutics Ltd (PsiOxus), formerly known as Myotec Therapeutics Ltd is a drug company that develops novel therapeutics for cancer and other clinically unmet diseases. The company provides pipeline product portfolio such as an oncolytic vaccine and a dual action anabolic catabolic t …
  • SunPower Corporation (SPWR):電力:M&Aディール及び事業提携情報
    Summary SunPower Corporation (SunPower), a subsidiary of Total Solar International SAS, is a provider of solar technology and energy services. The company has a presence in solar value chain from cell and panel manufacturing, project development, project finance through engineering, procurement, and …
  • Geron Corp (GERN)-製薬・医療分野:企業M&A・提携分析
    Summary Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆